[Specific inhibitory effects of anti-cancer drugs conjugated with anti-alpha-fetoprotein, a specific antibody to the AFP-producing yolk sac tumor].
Okawa
K
K
D000818:Animals; D000906:Antibodies / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis; D000939:Epitopes; D005260:Female; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy; D008649:Mesonephroma / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D000509:alpha-Fetoproteins / Q000096:biosynthesis / Q000276:immunology*
D000906:Antibodies; D000951:Antigens, Neoplasm; D004273:DNA, Neoplasm; D000939:Epitopes; D000509:alpha-Fetoproteins